Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Pacira Pharm Inc (PCRX)
Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,797,710
  • Shares Outstanding, K 45,989
  • Annual Sales, $ 666,820 K
  • Annual Income, $ 15,910 K
  • 60-Month Beta 0.77
  • Price/Sales 2.62
  • Price/Cash Flow 9.47
  • Price/Book 2.28
Trade PCRX with:

Options Overview Details

View History
  • Implied Volatility 51.14% ( +7.06%)
  • Historical Volatility 34.18%
  • IV Percentile 62%
  • IV Rank 64.30%
  • IV High 76.52% on 02/27/23
  • IV Low 5.42% on 11/07/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 114
  • Put/Call OI Ratio 1.10
  • Today's Open Interest 3,745
  • Open Int (30-Day) 4,565

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.66
  • Number of Estimates 5
  • High Estimate 0.70
  • Low Estimate 0.64
  • Prior Year 0.34
  • Growth Rate Est. (year over year) +94.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.63 +6.72%
on 06/01/23
45.45 -13.99%
on 05/03/23
-7.36 (-15.84%)
since 05/02/23
3-Month
36.63 +6.72%
on 06/01/23
48.60 -19.57%
on 05/01/23
-3.17 (-7.50%)
since 03/02/23
52-Week
35.35 +10.58%
on 01/23/23
65.65 -40.46%
on 06/03/22
-26.18 (-40.11%)
since 06/02/22

Most Recent Stories

More News
bluebird (BLUE) Posts Q1 Earnings, Focuses on Zynteglo, Skysona

bluebird bio (BLUE) delivers earnings of 21 cents per share in the first quarter, due to a one-time gain. Revenues increase year over year.

LGND : 75.31 (+5.77%)
PCRX : 39.09 (+2.76%)
BLUE : 3.63 (+2.54%)
SPRO : 1.8200 (+1.11%)
Viatris (VTRS) Q1 Earnings Beat, Revenues Miss Estimates

Viatris (VTRS) beats on Q1 earnings but misses sales. The company is now looking to reshape its business after selling its biosimilars portfolio.

LGND : 75.31 (+5.77%)
PCRX : 39.09 (+2.76%)
SPRO : 1.8200 (+1.11%)
VTRS : 9.33 (+1.63%)
Pacira (PCRX) Q1 Earnings Miss Estimates, Revenues Beat

Pacira (PCRX) misses on Q1 earnings but beats on revenues, even though volume growth of Exparel is offset by lower selling prices.

LGND : 75.31 (+5.77%)
PCRX : 39.09 (+2.76%)
FATE : 5.25 (+3.55%)
SPRO : 1.8200 (+1.11%)
Compared to Estimates, Pacira (PCRX) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Pacira (PCRX) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to...

PCRX : 39.09 (+2.76%)
Pacira (PCRX) Lags Q1 Earnings Estimates

Pacira (PCRX) delivered earnings and revenue surprises of -11.67% and 2.12%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PCRX : 39.09 (+2.76%)
COLL : 21.63 (-3.22%)
Pacira: Q1 Earnings Snapshot

Pacira: Q1 Earnings Snapshot

PCRX : 39.09 (+2.76%)
Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More

Let us take a look at what's in store for biotech/drug stocks UTHR, PCRX, CORT, AMRN and IONS, which are scheduled to report on May 3.

UTHR : 217.22 (+1.75%)
PCRX : 39.09 (+2.76%)
AMRN : 1.2800 (+5.79%)
CORT : 23.26 (+1.26%)
IONS : 41.75 (-2.77%)
Marinus Pharmaceuticals (MRNS) Stock Jumps 8.4%: Will It Continue to Soar?

Marinus Pharmaceuticals (MRNS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the...

MRNS : 7.39 (+2.35%)
PCRX : 39.09 (+2.76%)
Why Is Pacira (PCRX) Down 6% Since Last Earnings Report?

Pacira (PCRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PCRX : 39.09 (+2.76%)
Pacira's (PCRX) sNDA for Exparel Accepted for FDA Review

The FDA accepts Pacira's (PCRX) sNDA filing, which seeks to expand the label of its pain drug Exparel to include both sciatic and femoral nerve blocks. A final decision is expected by November 2023.

PCRX : 39.09 (+2.76%)
RCEL : 13.67 (+10.06%)
AVTX : 2.89 (+3.21%)
EQRX : 1.8300 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers. These products are developed using the company's proprietary DepoFoam drug...

See More

Key Turning Points

3rd Resistance Point 40.93
2nd Resistance Point 40.14
1st Resistance Point 39.61
Last Price 39.09
1st Support Level 38.29
2nd Support Level 37.50
3rd Support Level 36.97

See More

52-Week High 65.65
Fibonacci 61.8% 54.08
Fibonacci 50% 50.50
Fibonacci 38.2% 46.92
Last Price 39.09
52-Week Low 35.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar